October 4, 2023
Moderna’s combo vaccine shows strong immunogenicity against influenza and COVID-19
Moderna announced Wednesday positive results from a clinical trial of mRNA-1083, its combination mRNA combination flu/COVID vaccine.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: COVID-19 vaccine
November 14, 2022
Moderna’s biovalent booster candidates meet primary endpoint of superiority against Omicron variants in trai
Moderna said Monday that both of its bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger a superior antibody response compared…
April 20, 2022
Moderna: Clinical update on bivalent COVID-19 booster platform
Moderna has announced new clinical data on its bivalent COVID-19 booster platform including data on the company’s first bivalent booster candidate, mRNA-1273.211, which includes mutations found in the Beta variant of concern, several of which have been persistent in more recent variants of concern including Omicron.
April 14, 2022
Valneva’s Inactivated Covid-19 Vaccine Gets CMA in UK
The Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom has granted Conditional Marketing Authorization (CMA) for Valneva’s inactivated whole-virus COVID-19 vaccine candidate, VLA2001, for primary immunization in adults 18 to 50 years of age.